Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about following events for which disclosure as required under Regulation 30 read with sub-clause 7 of Para A of Part A of Schedule III:1.Confirmation of appointment of Joshi Sahay and Company, Practicing Company Secretary (Unique Code: P2025MP322400 and Peer Review Certificate No.: 6873/2025) as Secretarial Auditor of the Company and fix their remuneration - attached as Annexure-I.2.Confirmation of re-appointment of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Independent Director, for a second term of 5 years commencing from 25th August, 2025 to 24th August, 2030, - attached as Annexure-II. 3.Confirmation of re-appointment of Mr. Satish Beohar (DIN: 09220291) as Independent Director, for a second term of 5 years commencing from 30th June, 2026 to 29th June, 2031, - attached as Annexure-II.4.Confirmation for Change in designation of Mr. Ketan Shah (DIN: 08818212) from Whole Time Director to Chairman and Managing Director - attached as Annexure-III5.Confirmation of appointment of Mr. Smitesh Shah (DIN: 00326182) as a Promoter Non Executive Non-Independent Director of the Company - attached as Annexure-IV.